Claudin and p53 expression in vulvar lichen sclerosus and squamous-cell carcinoma

Journal of Clinical Pathology

Volumn 64, Issue 10, 2011, Pages 853-857

  Sadalla, José Carlos ^a   Lourenço, Sílvia Vanessa ^a   Sotto, Mirian Nacagami ^a   Baracat, Edmund Chada ^a   Carvalho, Jesus Paula ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CLAUDIN; CLAUDIN 1; CLAUDIN 11; CLAUDIN 2; CLAUDIN 3; CLAUDIN 4; CLAUDIN 5; CLAUDIN 7; PROTEIN P53;

ADULT; AGED; ARTICLE; CANCER GROWTH; CANCER PATIENT; CANCER STAGING; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; LICHEN SCLEROSUS ET ATROPHICUS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA;

AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; BRAZIL; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; CLAUDINS; DISEASE PROGRESSION; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; NEOPLASM STAGING; TIME FACTORS; TISSUE ARRAY ANALYSIS; TUMOR SUPPRESSOR PROTEIN P53; UP-REGULATION; VULVAR LICHEN SCLEROSUS; VULVAR NEOPLASMS;

EID: 80053197784     PISSN: 00219746     EISSN: 14724146     Source Type: Journal    
DOI: 10.1136/jclinpath-2011-200103     Document Type: Article

References (51)

1. FIGO Committee on Gynecologic Oncology and IGCS Guidelines Committee. Staging Classifications and Clinical Practice Guidelines of Gynaecologic Cancers. USA: FIGO, 2nd edn, 2003.
2. De Hullu JA, van der Zee AG. Surgery and radiotherapy in vulvar cancer. USA: FIGO, Crit Rev Oncol Hematol 2006;60:38-58. (Pubitemid 44332964)
3. Fons G, Burger MP, Kate FJ, et al. Identification of potential prognostic markers for vulvar cancer using immunohistochemical staining of tissue microarrays. Int J Gynecol Pathol 2007;26:188-93. (Pubitemid 46573217)
4. Preti M, Mezzetti M, Robertson C, et al. Inter-observer variation in histopathological diagnosis and grading of vulvar intraepithelial neoplasia: results of an European collaborative study. BJOG 2000;107:594-9. (Pubitemid 30242850)
5. Jones RW, Rowan DM, Stewart AW. Vulvar intraepithelial neoplasia: aspects of the natural history and outcome in 405 women. Obstet Gynecol 2005;106:1319-26. (Pubitemid 41668952)
6. Sideri M, Jones RW, Wilkinson EJ, et al. Squamous vulvar intraepithelial neoplasia: 2004 modified terminology, ISSVD Vulvar Oncology Subcommittee. J Reprod Med 2005;50:807-10. (Pubitemid 41720964)
7. Scurry J, Campion M, Scurry B, et al. Pathologic audit of 164 consecutive cases of vulvar intraepithelial neoplasia. Int J Gynecol Pathol 2006;25:176-81. (Pubitemid 44620182)
8. Scurry J, Wilkinson EJ. Review of terminology of precursors of vulvar squamous cell carcinoma. J Low Genit Tract Dis 2006;10:161-9. (Pubitemid 44618506)
9. van der Avoort IA, Shirango H, Hoevenaars BM, et al. Vulvar squamous cell carcinoma is a multifactorial disease following two separate and independent pathways. Int J Gynecol Pathol 2006;25:22-9. (Pubitemid 44638331)
10. Ueda Y, Enomoto T, Kimura T, et al. Two distinct pathways to development of squamous cell carcinoma of the vulva. J Skin Cancer 2011;2011:951250.
11. Meffert JJ, Davis BM, Grimwood RE. Lichen sclerosus. J Am Acad Dermatol 1995;32:393-416; quiz 417-18.
12. Rolfe KJ, MacLean AB, Crow JC, et al. TP53 mutations in vulval lichen sclerosus adjacent to squamous cell carcinoma of the vulva. Br J Cancer 2003;89:2249-53. (Pubitemid 38168007)
13. Pugliese JM, Morey AF, Peterson AC. Lichen sclerosus: review of the literature and current recommendations for management. J Urol 2007;178:2268-76. (Pubitemid 350052170)
14. Jeffcoate TN, Woodcock AS. Premalignant conditions of the vulva, with particular reference to chronic epithelial dystrophies. BMJ 1961;2:127-34.
15. Wallace HJ. Lichen sclerosus et atrophicus. Trans St Johns Hosp Dermatol Soc 1971;57:9-30.
16. Hart WR, Norris HJ, Elwig EB. Relation of lichen sclerosus et atrophicus of the vulva to the development of carcinoma. Obstet Gynecol 1975;45:369-77.
17. Friedrich EG Jr. Vulval dystrophy. Clin Obstet Gynecol 1985;28:178-87.
18. Meyrick Thomas RH, Ridley CM, McGibbon DH, et al. Lichen sclerosus et atrophicus and autoimmunity - a study of 350 women. Br J Dermatol 1988;118:41-6.
19. Carlson JA, Ambros R, Malfetano J, et al. Vulvar lichen sclerosus and squamous cell carcinoma: a cohort, case control, and investigational study with historical perspective; implications for chronic inflamation and sclerosis in the development of neoplasia. Hum Pathol 1998;29:932-48. (Pubitemid 28422041)
20. Leibowitch M, Neill S, Pelisse M, et al. The epithelial changes associated with squamous cell carcinoma of the vulva: a review of the clinical, histological and viral findings in 78 women. Br J Obstet Gynaecol 1990;97:1135-9.
21. Scurry J, Whitehead J, Healey M. Histology of lichen sclerosus varies according to site and proximity to carcinoma. Am J Dermatopathol 2001;23:413-18. (Pubitemid 32938911)
22. Chiesa-Vottero A, Dvoretsky PM, Hart WR. Histopathologic study of thin vulvar squamous cell carcinomas and associated cutaneous lesions: a correlative study of 48 tumors in 44 patients with analysis of adjacent vulvar intraepithelial neoplasia types and lichen sclerosus. Am J Surg Pathol 2006;30:310-18. (Pubitemid 43740162)
23. Kuribayashi K, El-Deiry WS. Regulation of programmed cell death by the p53 pathway. Adv Exp Med Biol 2008;615:201-21.
24. Corney DC, Flesken-Nikitin A, Choi J, et al. Role of p53 and Rb in ovarian cancer. Adv Exp Med Biol 2008;622:99-117.
25. Lahat G, Lazar A, Lev D. Sarcoma epidemiology and etiology: potential environmental and genetic factors. Surg Clin North Am 2008;88:451-81, v. (Pubitemid 351734513)
26. Tomkova K, Tomka M, Zajac V. Contribution of p53, p63, and p73 to the developmental diseases and cancer. Neoplasma 2008;55:177-81.
27. Rolfe KJ, Eva LJ, MacLean AB, et al. Cell cycle proteins as molecular markers of malignant change in vulvar lichen sclerosus. Int J Gynecol Cancer 2001;11:113-18. (Pubitemid 32381659)
28. Sawada N, Murata M, Kikuchi K, et al. Tight junctions and human diseases. Med Electron Microsc 2003;36:147-56. (Pubitemid 37288275)
29. Utech M, Brüwer M, Nusrat A. Tight junctions and cell-cell interactions. Methods Mol Biol 2006;341:185-95.
30. Koval M. Claudins - key pieces in the tight junction puzzle. Cell Commun Adhes 2006;13:127-38. (Pubitemid 44349316)
31. Saeki R, Kondoh M, Kakutani H, et al. A novel tumor-targeted therapy using a claudin-4-targeting molecule. Mol Pharmacol 2009;76:918-26.
32. Itallie CM, Anderson JM. The role of claudins in determining paracellular charge selectivity. Proc Am Thorac Soc 2004;1:38-41.
33. Balkovetz DF. Claudins at the gate: determinants of renal epithelial tight junction paracellular permeability. Am J Physiol Renal Physiol 2006;290:F572-9. (Pubitemid 43724957)
34. Kondoh M, Takahashi A, Fujii M, et al. A novel strategy for a drug delivery system using a claudin modulator. Biol Pharm Bull 2006;29:1783-9. (Pubitemid 44338395)
35. Lourenço SV, Coutinho-Camillo CM, Buim ME, et al. Oral squamous cell carcinoma: status of tight junction claudins in the different histopathological patterns and relationship with clinical parameters. A tissue-microarray-based study of 136 cases. J Clin Pathol 2010;63:609-14.
36. Lourenço SV, Coutinho-Camillo CM, Buim ME, et al. Claudin-7 down-regulation is an important feature in oral squamous cell carcinoma. Histopathology 2010;57:689-98.
37. Lee JW, Lee SJ, Seo J, et al. Increased expressions of claudin-1 and claudin-7 during the progression of cervical neoplasia. Gynecol Oncol 2005;97:53-9. (Pubitemid 40403674)
38. Sobel G, Paska C, Szabo I, et al. Increased expression of claudins in cervical squamous intraepithelial neoplasia and invasive carcinoma. Hum Pathol 2005;36:162-9. (Pubitemid 40320530)
39. Zhu Y, Brännström M, Janson PO, et al. Differences in expression patterns of the tight junction proteins, claudin 1, 3, 4 and 5, in human ovarian surface epithelium as compared to epithelia in inclusion cysts and epithelial ovarian tumours. Int J Cancer 2006;118:1884-91.
40. Agarwal R, D'Souza T, Morin PJ. Claudin-3 and claudin-4 expression in ovarian epithelial cells enhances invasion and is associated with increased matrix metalloproteinase-2 activity. Cancer Res 2005;65:7378-85. (Pubitemid 41161271)
41. Choi YL, Kim J, Kwon MJ, et al. Expression profile of tight junction protein claudin 3 and claudin 4 in ovarian serous adenocarcinoma with prognostic correlation. Histol Histopathol 2007;22:1185-95. (Pubitemid 47470312)
42. Aravindakshan J, Chen X, Sairam MR. Differential expression of claudin family proteins in mouse ovarian serous papillary epithelial adenoma in aging FSH receptordeficient mutants. Neoplasia 2006;8:984-94.
43. Santin AD, Bellone S, Siegel ER, et al. Overexpression of Clostridium perfringens enterotoxin receptors claudin-3 and claudin-4 in uterine carcinosarcomas. Clin Cancer Res 2007;13:3339-46. (Pubitemid 46944921)
44. Kominsky SL, Argani P, Korz D, et al. Loss of the tight junction protein claudin-7 correlates with histological grade in both ductal carcinoma in situ and invasive ductal carcinoma of the breast. Oncogene 2003;22:2021-33. (Pubitemid 36523639)
45. Sauer T, Pedersen MK, Ebeltoft K, et al. Reduced expression of Claudin-7 in fine needle aspirates from breast carcinomas correlate with grading and metastatic disease. Cytopathology 2005;16:193-8. (Pubitemid 41112978)
46. Soini Y. Claudins 2, 3, 4, and 5 in Paget's disease and breast carcinoma. Hum Pathol 2004;35:1531-6. (Pubitemid 40017994)
47. Santin AD, Bellone S, Marizzoni M, et al. Overexpression of claudin-3 and claudin-4 receptors in uterine serous papillary carcinoma: novel targets for a type-specific therapy using Clostridium perfringens enterotoxin (CPE). Cancer 2007;109:1312-22. (Pubitemid 46466558)
48. Konecny GE, Agarwal R, Keeney GA, et al. Claudin-3 and claudin-4 expression in serous papillary, clear-cell, and endometrioid endometrial cancer. Gynecol Oncol 2008;109:263-9.
49. Kleinberg L, Holth A, Trope CG, et al. Claudin upregulation in ovarian carcinoma effusions is associated with poor survival. Hum Pathol 2008;39:747-57. (Pubitemid 351618309)
50. Liegl B, Regauer S. p53 immunostaining in lichen sclerosus - an under recognized feature? Histopathology 2004;45:237-44.
51. Liegl B, Regauer S. Vasculitis in lichen sclerosus is related to ischaemic stress and is not a marker of differentiated vulvar intraepithelial neoplasia (d-VIN). Histopathology 2006;48:268-74.